Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction
暂无分享,去创建一个
R. Stevens | J. Dupuy | M. Kiso | P. Stenmark | A. Imamura
[1] T. Tsuji,et al. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. , 2008, Microbial pathogenesis.
[2] Eric A. Johnson,et al. Jcb: Article , 2022 .
[3] M. Popoff,et al. Receptor‐mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers , 2007, Cellular microbiology.
[4] T. Weil,et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept , 2007, Proceedings of the National Academy of Sciences.
[5] Axel T. Brunger,et al. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.
[6] R. Stevens,et al. Structural basis of cell surface receptor recognition by botulinum neurotoxin B , 2006, Nature.
[7] D. V. van Aalten,et al. Siglec-7 Undergoes a Major Conformational Change When Complexed with the α(2,8)-Disialylganglioside GT1b* , 2006, Journal of Biological Chemistry.
[8] Eric A. Johnson,et al. SV2 Is the Protein Receptor for Botulinum Neurotoxin A , 2006, Science.
[9] K. Takeuchi,et al. Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid , 2005, Journal of Biological Chemistry.
[10] R. Bhidayasiri,et al. Expanding use of botulinum toxin , 2005, Journal of the Neurological Sciences.
[11] Axel T Brunger,et al. New insights into clostridial neurotoxin-SNARE interactions. , 2005, Trends in molecular medicine.
[12] Leonard A. Smith,et al. N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B. , 2005, Biochemical and biophysical research communications.
[13] S. K. Sharma,et al. Clostridium botulinum: A Bug with Beauty and Weapon , 2005, Critical reviews in microbiology.
[14] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[15] H. Bigalke,et al. Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G* , 2004, Journal of Biological Chemistry.
[16] C. Schengrund,et al. Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. , 2004, Biochemistry.
[17] H. Bigalke,et al. The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction , 2003, Molecular microbiology.
[18] Xavier Robert,et al. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins , 2003, Nucleic Acids Res..
[19] J. Alves,et al. Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. , 2003, Journal of molecular biology.
[20] K. Acharya,et al. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. , 2002, Trends in biochemical sciences.
[21] C. Schengrund,et al. Botulinum Neurotoxin A Activity Is Dependent upon the Presence of Specific Gangliosides in Neuroblastoma Cells Expressing Synaptotagmin I* , 2002, The Journal of Biological Chemistry.
[22] P. Emsley,et al. The Crystal Structure of Tetanus Toxin Hc Fragment Complexed with a Synthetic GT1b Analogue Suggests Cross-linking between Ganglioside Receptors and the Toxin* , 2001, The Journal of Biological Chemistry.
[23] S. Swaminathan,et al. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B , 2000, Nature Structural Biology.
[24] R. Stevens,et al. Sequence homology and structural analysis of the clostridial neurotoxins. , 1999, Journal of molecular biology.
[25] Anastassis Perrakis,et al. Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.
[26] R. Stevens,et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.
[27] A. Vagin,et al. MOLREP: an Automated Program for Molecular Replacement , 1997 .
[28] S. Kozaki,et al. Interaction between botulinum neurotoxin type A and ganglioside: ganglioside inactivates the neurotoxin and quenches its tryptophan fluorescence. , 1997, Toxicon : official journal of the International Society on Toxinology.
[29] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[30] S. Teneberg,et al. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Martial,et al. Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.
[32] Wolfgang Kabsch,et al. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .
[33] M. Kiso,et al. A synthetic approach to polysialogangliosides containing alpha-sialyl-(2-->8)-sialic acid: total synthesis of ganglioside GD3. , 1993, Carbohydrate research.
[34] C. Montecucco. How do tetanus and botulinum toxins bind to neuronal membranes , 1986 .
[35] C. Shone,et al. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. , 1985, European journal of biochemistry.
[36] H. Elwing,et al. Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. , 1980, European journal of biochemistry.
[37] J. Barbieri,et al. Botulinum neurotoxin B–host receptor recognition: it takes two receptors to tango , 2007, Nature Structural &Molecular Biology.
[38] R. Stevens,et al. Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin , 2007, Nature Biotechnology.
[39] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[40] C. Schengrund,et al. Glycosphingolipids—Sweets for botulinum neurotoxin , 2004, Glycoconjugate Journal.
[41] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[42] K Henrick,et al. Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .